Home41O • FRA
add
Outlook Therapeutics Inc
Previous close
€1.53
Day range
€1.44 - €1.54
Year range
€0.85 - €8.30
Market cap
56.92M USD
Avg Volume
586.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.39M | -34.57% |
Net income | -46.36M | 59.44% |
Net profit margin | — | — |
Earnings per share | -0.34 | 78.23% |
EBITDA | -12.36M | 34.63% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.56M | -84.00% |
Total assets | 19.08M | -67.68% |
Total liabilities | 51.54M | -73.33% |
Total equity | -32.46M | — |
Shares outstanding | 33.57M | — |
Price to book | -1.54 | — |
Return on assets | -171.72% | — |
Return on capital | 336.64% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -46.36M | 59.44% |
Cash from operations | -16.58M | 13.93% |
Cash from investing | — | — |
Cash from financing | 18.44M | -67.16% |
Net change in cash | 1.85M | -94.97% |
Free cash flow | -10.98M | 15.77% |
About
Founded
2010
Website
Employees
23
